Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Oldbring BioVäxt AB
AB
Active
Org 5591493506
Ingelstorpsvägen 268, 262 92
Ängelholm
Manufacture of fertilisers and nitrogen compounds
·
NACE 2015
Est. 2018 · 8 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of fertilisers and nitrogen compounds
/
Oldbring BioVäxt AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2020: 3M
3M
2020
2021: 2M (-33% vs 2020)
2M
-33%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
EBITDA
SEK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
1 507
2 035
2 268
3 194
Staff expenses
—
—
—
—
—
EBITDA
−131
1 092
866
657
1 427
Depreciation & amort.
−0
−774
−879
−879
−837
EBIT
−131
318
−13
−222
590
Net financials
−48
−126
−124
−126
−189
Profit before tax
7
6
27
2
7
Tax
−7
−2
−0
−1
−2
Net profit
0
4
27
1
5
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
422
3 237
4 275
5 152
5 737
Equity
93
92
88
61
60
Long-term debt
0
2 650
3 760
4 570
4 180
Short-term debt
329
309
426
356
983
Total debt
329
2 959
4 186
4 926
5 163
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
22,0 %
This company
38,2 %
Market median
This company
Market median
42% below market
2020
2024
Return on equity
0,0 %
This company
18,4 %
Market median
This company
Market median
100% below market
2020
2024
Net profit margin
0,0 %
This company
8,1 %
Market median
This company
Market median
100% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
3,54×
This company
0,62×
Market median
This company
Market median
471% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Oldbring BioVäxt AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
